Based on these observations, we set out to examine the impact of combined CREBBP and KMT2D haploinsufficiency in vivo and explored how these two tumor suppressors functionally interact in normal and malignant GC B cells to promote oncogenesis. This evidence concerns the gene CREBBP and neoplasm.